Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidTara Graff
    Ask Trek AI about this page

    Tara Graff — Billing Profile & Reimbursement Data

    NPI 1356584080 · Clive, IA · Medical Oncology Physician

    Customize your policy alerts

    Sign up for Tara Graff — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Tara Graff is a medical oncology physician provider located in Clive, Iowa. This profile covers 65 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationTara Graff
    Address12495 University Ave Ste 200
    CityClive
    StateIA
    ZIP50325
    TaxonomyMedical Oncology Physician
    NPI EnumeratedApril 10, 2009

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$1.4M
    Medicaid$0

    Key Findings

    This provider is a medical oncology physician in Clive, IA with a long Medicare billing history; the NPI was enumerated on 2009-04-10 (~17 years ago), indicating sustained activity under this billing identity. The mix of high-volume injectable drug codes and oncology E/M and infusion codes aligns with an outpatient oncology practice that provides in-office systemic therapy and follow-up visits.

    Medicare dominates this provider's public payer activity — lifetime Medicare revenue is $1.4M and there is no Medicaid billing on file, so the practice is effectively single-payer in the available claims data and reliant on Medicare for observable public reimbursement.

    Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 69.5% of the provider's total Medicare revenue, showing that a small set of therapies drives most of billings. The leading single code is J9271, which alone represents $576.2K (43.2% of Medicare revenue), indicating heavy dependence on pembrolizumab administrations.

    The top three drugs billed are oncology-focused biologics: J9271 (pembrolizumab), J0897 (denosumab), and J1569 (immune globulin), together composing the majority of revenue and pointing to a service line centered on immunotherapy/biologic treatment and supportive agents commonly used in cancer care. This mix suggests the practice primarily delivers drug administration rather than generating most revenue from ancillary procedures.

    Competitive standing by national rank is mixed across codes. For J9271 the provider ranks #806 of 1841 (55th percentile), a middle-of-market volume for pembrolizumab; by contrast J0897 ranks #687 of 10057 (93th percentile), indicating substantially higher relative volume for denosumab versus the national peer set. Other administered drugs like Q5115 (rituximab biosimilar) show a concentrated footprint (#44 of 79 providers), which suggests local niche activity for that biosimilar.

    There are notable statistical outliers in outpatient E/M volume: 99214 appears as an "extreme outlier, far above typical national volume for this code" (1.1K claims, $92.2K revenue), and 99215 is "notably above typical national volume" (271 claims, $34.7K). These elevated E/M volumes imply the provider maintains substantial longitudinal established-patient clinic activity in addition to drug administration.

    Infusion and chemotherapy administration codes appear at typical volumes for an oncology practice: 96413, 96365, 96417 and related infusion add-on codes are present but account for smaller shares of revenue (each is a low-single-digit percent or less), signaling that while IV chemo and infusion support are offered, expensive immunotherapy agents dominate reimbursement.

    Laboratory and routine procedure codes (80053 CMP, 85025 CBC, 36415 phlebotomy, and 82784 immunoglobulin testing) appear with many claims but low per-claim payments and together represent small shares of revenue; their high national percentiles (many 90s) reflect frequent utilization that supports clinic-based oncology care rather than primary revenue drivers.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    65 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J9271Injection, pembrolizumab, 1 mg13,400$40$576.2K
    J0897Injection, denosumab, 1 mg13,260$20$238.7K
    J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg3,230$40$113K
    99214The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…1,070$90$92.2K
    Q5115Injection, rituximab-abbs, biosimilar, (truxima), 10 mg2,480$40$89.3K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…380$90$35.3K
    99215The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…270$130$34.7K
    J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg370$80$30.9K
    99233The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…190$90$17.1K
    96367The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…550$20$11.5K

    Showing 1–10 of 65

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    65 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J9271193017,200$40$902.3K
    J15694102,680$40$133.6K
    J0897131901,920$20$74.1K
    Q51152101,790$30$71.4K
    J25061020440$80$38.9K
    964131980210$90$24K
    J01859206,890$1$14.5K
    99214494,690100$70$14.4K
    9923316391060$90$10.5K
    992321,3691,74080$60$9.3K

    Showing 1–10 of 65

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Tara Graff, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    State University Of IowaIAFamily Medicine Physician$0$103.8M
    State University Of IowaIAGeneral Acute Care Hospital$0$90.4M
    State University Of IowaIADentist$0$25.8M
    Thomas BurokerIAMedical Oncology Physician$9.4M$0
    Kyle AllimanIAOphthalmology Physician$8.7M$0
    Alex KartvelishviliIAOphthalmology Physician$8.1M$0
    Paul BoekeIAOphthalmology Physician$7.1M$0
    Austin StrohbehnIARetina Specialist (Ophthalmology) Physician$5.8M$0
    Jeremy DeutschKSHematology & Oncology Physician$5.7M$0
    State University Of IowaIADentist$0$5.6M

    Nearby Providers

    Other providers in the same ZIP code as Tara Graff, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Iowa Family AssistantsIAHome Health Agency$0$18M
    Iowa Radiology, P CIADiagnostic Radiology Physician$0$5.2M
    Mercy Clinics, Inc.IAPrimary Care Clinic/Center$0$2.9M
    Iowa Diagnostic Imaging & Procedure Center, L CIADiagnostic Radiology Physician$0$2.5M
    Iowa Endoscopy Center, Inc.IAAmbulatory Surgical Clinic/Center$774K$1.5M
    West Lakes Surgery Center LLCIAAmbulatory Surgical Clinic/Center$1.1M$1.1M
    Mercy Clinics IncIAClinic/Center$0$1.7M
    Catholic Health Initiatives-iowa CorpIADiagnostic Radiology Physician$594.7K$594.4K
    Phippsburger IncIAHome Health Agency$0$1.1M
    Uhs Midwest Behavioral Health LLCIAPsychiatry Physician$0$979.3K

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Iowa Distribution
    Tara Graff — 8 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Iowa